Pens – Cellgenic

Chronos: (MOTS-c + AMPK Activator)

Oliverbravo — Sat, 27 Sep 2025 18:43:50 +0000

What is Chronos MOTS-C Complex?

The combination of mitochondrial-derived peptide MOTS-c with an AMP-activated protein kinase (AMPK) activator represents a novel and synergistic approach to modulating metabolism, enhancing mitochondrial function, and optimizing cellular resilience. Both compounds converge on the AMPK-PGC-1α axis and offer complementary mechanisms that address metabolic dysfunction, inflammation, and aging.

Chronos MOTS-C 10mg | AMPK Activator 25mg

EXTENDED PROTOCOL

MOTS-c Mechanism of Action:

MOTS-c is a 16-amino acid peptide encoded by mitochondrial DNA, acting as a retrograde signaling molecule from the mitochondria to the nucleus. It provides AMPK activation via AICAR mimetic function, enhances insulin sensitivity and glucose uptake, promotes fatty acid oxidation, and reduces oxidative stress through Nrf2 activation.

AMPK Activator Mechanism of Action:

AMPK activators stimulate the AMPK pathway either by mimicking AMP or inhibiting mitochondrial complex I. Key actions include mitochondrial biogenesis via PGC-1α, induction of autophagy via ULK1 activation, metabolic reprogramming toward fatty acid oxidation, and anti-inflammatory effects via NF-κB inhibition.

Synergistic Integration:

The synergy is primarily based on their joint activation of the AMPK-PGC-1α axis through complementary mechanisms. This dual approach creates sustained AMPK activation, improved glucose homeostasis, enhanced fat metabolism, boosted energy output, robust anti-inflammatory effects, and slowed biological aging.

Clinical Applications:

Metabolic Optimization – Enhances insulin sensitivity, glucose uptake, and fatty acid oxidation.
Mitochondrial Support – Stimulates biogenesis, boosts energy output, reduces mitochondrial decay.
Longevity & Anti-Senescence – Activates FOXO and SIRT signaling, enhances autophagy and mitophagy.
Inflammation & Stress Resistance – Lowers NF-κB activity, improves recovery from metabolic stress.
Weight Management – Supports metabolic syndrome recovery and healthy body composition.
Performance Optimization – Provides exercise-mimetic effects to extend healthspan.

Dosage & Administration:

25–100 IU via subcutaneous (SC) or intramuscular (IM) route. Frequency: 3–7 times per week (daily or near-daily).

Cycle Length:

6–12 weeks for metabolic optimization and mitochondrial support. Best results observed with continuous use. Cycles can be repeated for ongoing support.

Reassessment:

After 30 days to adjust dosing and frequency based on individual response and metabolic markers.

Monitoring Parameters:

Glucose control markers (fasting glucose, HbA1c), mitochondrial performance indicators (VO₂ max, lactate threshold), and inflammation markers (CRP, IL-6).

Especially relevant for longevity medicine, metabolic syndrome, performance optimization, and immune modulation applications.

Synergistic Pathway Benefits:

AMPK Activation – Indirect via AICAR-mimetic + Direct activation = Sustained AMPK activation
Glucose Metabolism – GLUT4 upregulation + Insulin sensitivity = Improved glucose homeostasis
Fat Oxidation – β-oxidation promotion + ACC inhibition = Enhanced fat metabolism
Mitochondrial Health – Mitophagy enhancement + Biogenesis induction = Boosted energy output
Inflammation Control – Nrf2 activation + NF-κB inhibition = Robust anti-inflammatory effect
Longevity – Senescence reduction + Autophagy & mTOR inhibition = Slowed biological aging

The post Chronos: (MOTS-c + AMPK Activator) appeared first on Cellgenic.

Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed)

Oliverbravo — Sat, 27 Sep 2025 18:39:47 +0000

What is Eon LL-37 Complex?

A comprehensive antimicrobial and immune modulation formulation combining LL-37 cathelicidin with enhanced EGCG and Quercetin. This synergistic blend provides broad-spectrum pathogen clearance, immune rebalancing, mucosal barrier repair, and anti-senescence effects for chronic infections, autoimmune conditions, and post-viral recovery.

Eon LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed)

EXTENDED PROTOCOL

LL-37:

Cationic antimicrobial peptide derived from cathelicidin (hCAP18). Disrupts bacterial, viral, and fungal membranes; effective against biofilms. Activates Toll-like receptors (TLR2, TLR9) and enhances chemotaxis of immune cells. Promotes angiogenesis and epithelial regeneration.

EGCG (Inclusion Complexed):

Polyphenol from green tea with enhanced bioavailability via cyclodextrin inclusion. Scavenges ROS and chelates metals; activates Nrf2. Suppresses NF-κB, IL-6, and TNF-α; reduces mast cell activation. Blocks viral entry and replication; interferes with bacterial quorum sensing.

Quercetin (Inclusion Complexed):

Flavonoid with enhanced absorption via cyclodextrin inclusion. Stabilizes mast cells, reducing histamine, prostaglandins, and leukotrienes. Inhibits NF-κB, COX-2, iNOS; acts as a zinc ionophore. Senolytic properties: clears senescent cells and suppresses SASP.

Synergistic Integration:

Multi-pathway pathogen kill, superior biofilm eradication, balanced immune response, mucosal resilience, chronic inflammation suppression, and tissue longevity through complementary mechanisms.

Strategic Applications:

Post-viral recovery (EBV, COVID) – viral clearance, immune regulation, anti-fibrosis.
MCAS / Histamine intolerance – mast cell stabilization and histamine burden reduction.
Autoimmune support (Hashimoto’s, lupus) – Treg upregulation + NF-κB suppression + barrier healing.
Gut/Lung Barrier Dysfunction – epithelial repair + inflammation control.
Chronic Infections (Lyme, Candida, SIBO) – biofilm destruction + antimicrobial + cytokine modulation.
Anti-aging & Inflammaging – senolytic + regenerative + anti-fibrotic effects.

Dosage & Administration:

25–100 IU via subcutaneous (SC), intramuscular (IM), or intravenous (IV) route. Frequency: 1–2 times per week.

Cycle Length:

2–4 weeks for antimicrobial effect or immune priming. Can be repeated depending on infection load or immune dysregulation status.

Clinical Applications:

Broad-spectrum antimicrobial action, immune priming & modulation, inflammation control & barrier protection, post-infection recovery, and anti-aging & inflammaging support.

Monitoring Parameters:

Inflammatory markers: CRP, IL-6, TNF-α. Immune profile: WBC differential, Treg/Th17 balance. Clinical outcomes: infection clearance, symptom regression, mucosal/gut health.

Especially valuable for patients with chronic infections, autoimmune conditions, and post-viral recovery needs.

Mechanistic Pathways:

Antimicrobial – Multi-pathway pathogen disruption and biofilm eradication
Biofilm Disruption – Superior matrix breakdown and adhesion inhibition
Immune Modulation – TLR activation, Treg boost, mast cell stabilization
Barrier Protection – Epithelial restoration, tight junction support, mucosal resilience
Anti-Inflammatory – NF-κB suppression, Nrf2 activation, endotoxin neutralization
Senescence/Aging – Tissue regeneration, fibrosis reduction, senolytic activity

The post Eon: LL-37 2mg | EGCG 250mg (Inclusion Complexed) | Quercetin 250mg (Inclusion Complexed) appeared first on Cellgenic.

Elysia: Gonadorelin, Oxytocin, DHEA, and PT- 141 (Her)

Oliverbravo — Sat, 27 Sep 2025 18:31:17 +0000

What is Elysia?

Elysia is a female-optimized peptide complex designed to enhance sexual vitality, hormonal balance, and emotional intimacy. Its ingredients — Gonadorelin, Oxytocin, DHEA, and PT-141 — work synergistically across the hypothalamic-pituitary-gonadal (HPG) axis, neuroendocrine system, and limbic brain centers to address low libido, hormonal dysregulation, and intimacy challenges in women.

Elysia Gonadorelin (Synthetic GnRH) 1.4mg, Oxytocin 500mcg, DHEA (Dehydroepiandrosterone) 100mg, PT-141 (Bremelanotide) 1mg

EXTENDED PROTOCOL

Gonadorelin (Synthetic GnRH) 1.4mg:

Directly stimulates pituitary to release LH and FSH. Leads to estradiol and progesterone production in premenopausal women. Supports ovulation, fertility, and hormone cycling. Useful in hypogonadotropic hypogonadism, post-birth control, or amenorrhea.

Oxytocin 500mcg:

Enhances limbic system activation (emotion & bonding). Increases trust, empathy, and vulnerability. Improves vaginal lubrication and arousal. Facilitates blood flow and smooth muscle relaxation. Boosts orgasmic potential via uterine/vaginal contractions.

DHEA (Dehydroepiandrosterone) 100mg:

Converts to estrogen and testosterone locally in tissues (intracrinology). Enhances vaginal tissue health, elasticity, and sensitivity. Balances the stress response, especially under cortisol dominance. Improves mood, motivation, and libido.

PT-141 (Bremelanotide) 1mg:

Activates MC3R and MC4R in the brain to trigger sexual desire and arousal. Restores libido in hypoactive sexual desire disorder (HSDD). Enhances sexual motivation and receptivity. Works even when hormonal levels are normal but libido is low.

Additional Female Benefits:

Restores libido and lubrication after menopause or hormonal birth control.
Improves emotional vulnerability and trust in relationships.
Increases sexual receptivity and orgasmic intensity.
Reduces cortisol-driven sexual shutdown (Oxytocin + DHEA).
Boosts confidence, sensuality, and body-image through neuroendocrine activation.
Improves sexual health without synthetic hormone replacement.
Works with or without a functioning menstrual cycle.

Dosage & Administration:

10 IU daily via subcutaneous (SC) or intramuscular (IM) route. Cycle Length: 4–8 weeks or as clinically needed.

Special Consideration:

Dose should be reduced or paused during the menstrual cycle to avoid overstimulation of endogenous hormonal rhythms.

Clinical Applications:

Female hormonal remodeling, libido & sexual function enhancement, emotional intimacy & mood support, and vaginal & reproductive health improvement. Supports fertility signaling and ovulation when appropriate.

Monitoring Parameters:

Cycle regularity, libido scores, mood stability, and vaginal health should be tracked for optimization.

Duration: 4–8 weeks with flexibility to adjust based on cycle or symptoms.

Ideal Users of Elysia:

Women with low libido from stress, age, or medications
Women on or recovering from hormonal contraceptives or SSRI/SNRI medications
Women with postpartum hormone drop or anorgasmia
Perimenopausal and menopausal women seeking non-synthetic hormone support
Women in long-term relationships wanting to rekindle arousal and emotional bonding
Women needing HPG axis reactivation after stress-induced shutdown

The post Elysia: Gonadorelin, Oxytocin, DHEA, and PT- 141 (Her) appeared first on Cellgenic.

Andros: Kisspeptin, Oxytocin, and PT-141 (Him)

Oliverbravo — Sat, 27 Sep 2025 18:28:27 +0000

What is Andros?

Andros is a cutting-edge male peptide formulation that targets the hypothalamic-pituitary-gonadal (HPG) axis, libido enhancement, testosterone upregulation, and emotional bonding. Its active constituents—Kisspeptin, Oxytocin, and PT-141—synergize across endocrine and neurobehavioral pathways to restore, enhance, and stabilize male sexual function.

Andros Kisspeptin 1.5mg, Oxytocin 400mcg, and PT-141 1mg

EXTENDED PROTOCOL

Kisspeptin (KISS1 Peptide) 1.5mg:

Stimulates GnRH release via GPR54 (KISS1R), leading to increased LH and FSH secretion. Enhances Leydig cell responsiveness to LH, boosting natural testosterone production. Activates puberty onset, spermatogenesis, and maintains male reproductive capacity.

Oxytocin 400mcg:

Increases dopaminergic activity in pleasure/reward pathways (nucleus accumbens). Enhances erectile function and orgasm intensity via smooth muscle relaxation. Promotes emotional bonding, empathy, and post-coital mood stabilization.

PT-141 (Bremelanotide) 1mg:

Activates MC4R receptors in the hypothalamus to directly increase sexual arousal. Effective in men with low testosterone or vascular insufficiency. Enhances dopamine signaling and sexual motivation.

Synergistic Integration:

The combination creates neurovascular erection synergy, heightened arousal/motivation, enhanced natural testosterone production, and improved sexual + emotional connection through multiple pathway activation.

Additional Male Benefits:

Improves semen quality and spermatogenesis via FSH stimulation.
Restores libido in hypogonadal or overtrained males.
Useful in post-cycle therapy (PCT) as a non-suppressive testosterone booster.
Enhances emotional bonding during sex, reinforcing relationship cohesion.
Rescues sexual motivation in SSRI users with blunted dopamine responses.
Improves erectile function without cardiovascular stress.

Dosage & Administration:

10 IU daily via subcutaneous (SC) or intramuscular (IM) route. Cycle: 4–8 weeks, or as clinically needed for hormone modulation.

Clinical Applications:

Hormonal remodeling in males, libido & arousal enhancement, erectile function support, and emotional & social bonding improvement. Works independently of nitric oxide pathways as PDE5i alternative.

Monitoring Parameters:

Track testosterone, LH, FSH, and libido/arousal scores for optimization. Duration can be adjusted depending on response.

Can be combined with metabolic or regenerative therapies to optimize male vitality and performance.

Ideal Use Cases:

Men with low libido or borderline-low testosterone
Post-cycle therapy (PCT) for athletes to avoid suppression
Recovery from SSRI-induced sexual dysfunction
Performance anxiety or psychological erectile dysfunction
Couples seeking improved emotional + sexual connection
Biohackers seeking comprehensive male enhancement

The post Andros: Kisspeptin, Oxytocin, and PT-141 (Him) appeared first on Cellgenic.

Aegis: Thymosin Alpha 1 3.2mg | Thymalin 2.5mg | Ursolic Acid 25mg | RG3 Ginsenoside 50mg | AMPK Activator 50mg

Oliverbravo — Sat, 27 Sep 2025 18:24:33 +0000

What is Aegis Thymosin Alpha 1 Complex?

This peptide formulation combines thymic peptides with metabolic and immunomodulatory compounds: Thymosin Alpha 1, Thymalin, Ursolic Acid, RG3 Ginsenoside, and an AMPK Activator. Together, these agents synergize across immune restoration, anti-inflammation, metabolic regulation, anti-cancer activity, and antisenescence pathways.

Aegis Thymosin Alpha 1 3.2mg | Thymalin 2.5mg | Ursolic Acid 25mg | RG3 Ginsenoside 50mg | AMPK Activator 50mg

EXTENDED PROTOCOL

Thymosin Alpha 1:

Stimulates CD4+/CD8+ T-cell differentiation and Th1 immunity. Enhances dendritic cell function and MHC class I expression, suppresses NF-κB and chronic inflammation.

Thymalin:

Regulates gene expression via chromatin remodeling. Normalizes immune cell populations and rejuvenates thymic activity. Anti-senescence via telomerase support and inflammatory downregulation.

Ursolic Acid:

Activates AMPK, enhances mitochondrial function and fat oxidation. Inhibits NF-κB and STAT3 signaling (anti-inflammatory, anti-cancer). Reduces muscle wasting and supports metabolic regeneration.

RG3 Ginsenoside:

Inhibits NF-κB and COX-2 (inflammatory suppression). Blocks VEGF and MMP pathways to reduce tumor angiogenesis. Activates Nrf2 antioxidant defense and induces apoptosis in damaged cells.

AMPK Activator:

Increases PGC-1α and mitochondrial biogenesis. Induces autophagy via ULK1 activation. Suppresses mTOR and NF-κB (aging and inflammation dampening).

Clinical Applications:

Immune Restoration – Post-viral fatigue, immune suppression, and immunosenescence recovery.
Autoimmune Balancing – Normalizes overactive immune responses and reduces chronic inflammation.
Senescence Reversal / Longevity Protocols – Supports telomerase activity and reduces aging markers.
Metabolic & Fat Loss Support – Enhances fat oxidation and improves insulin sensitivity.
Muscle Maintenance & Recovery – Prevents muscle wasting during illness or aging.
Oncology Support (Adjunctive Use) – Reduces tumor angiogenesis and induces apoptosis in damaged cells.

Dosage & Administration:

50 IU – 100 IU per injection via subcutaneous (SC) or intramuscular (IM) route. Frequency: 3–7 times per week depending on immune status and therapeutic goals.

Cycle Duration:

Duration: 4–8 weeks, extendable for chronic immune modulation or longevity support. Standard cycle is repeatable depending on clinical need.

Monitoring Parameters:

Recommended to track inflammatory markers (CRP, IL-6), immune function (CD4/CD8 ratio), and metabolic markers (HbA1c, fasting insulin) for optimization.

Can be integrated with regenerative medicine protocols (stem cells, exosomes, NK cells) for synergistic effects on immune rejuvenation and systemic repair.

Synergy Map – Overlapping Targets:

Immune Rejuvenation – Enhance thymopoiesis, CD4+/CD8+ balance, and immune activation
Inflammation Control – Suppress NF-κB, IL-6, TNFα pathways
Anti-Senescence – Inhibit mTOR, activate telomerase, reduce senescence markers
Cancer Suppression – Apoptosis induction, immune surveillance, angiogenesis inhibition
Metabolic Enhancement – Increase fat oxidation, insulin sensitivity, mitochondrial function
Autophagy & Repair – Activate ULK1, support detoxification and damaged cell recycling

The post Aegis: Thymosin Alpha 1 3.2mg | Thymalin 2.5mg | Ursolic Acid 25mg | RG3 Ginsenoside 50mg | AMPK Activator 50mg appeared first on Cellgenic.

Axis: GHRP-2 + Ipamorelin + PEG-MGF + Thymalin + Tesamorelin)

Oliverbravo — Sat, 27 Sep 2025 18:20:39 +0000

What is Axis GHRP-2 Complex?

A comprehensive peptide formulation targeting multiple synergistic domains, creating a regenerative, anabolic, and autoimmune suppression stack for rheumatoid arthritis, tissue repair, and muscle regeneration.

Axis GHRP-2 1mg | Ipamorelin 2mg | PEG-MGF 100mcg | Thymalin 2mg | Tesamorelin 2mg

EXTENDED PROTOCOL

GHRP-2 (Growth Hormone Releasing Peptide-2):

Synthetic ghrelin mimetic binding to GHS-R1a receptor. Stimulates pulsatile GH release via hypothalamic and pituitary pathways, increases IGF-1 production promoting collagen synthesis, cartilage repair, and bone density.

Ipamorelin:

Selective GHS mimetic with minimal cortisol or prolactin stimulation. Binds GHS-R1a to trigger GH release without cortisol side effects, enhances bone turnover, cartilage preservation, and muscle mass.

PEG-MGF (Pegylated Mechano Growth Factor):

Splice variant of IGF-1 induced by injury; PEGylation increases half-life. Promotes myoblast proliferation and muscle repair, stimulates satellite cell activation in muscle and joint tissue.

Thymalin:

Thymus-derived peptide complex regulating immunity and cell differentiation. Balances T-helper subtypes (Th1/Th2/Th17/Treg), normalizes immune tolerance, reducing autoreactivity in RA.

Tesamorelin:

Stabilized GHRH analog resistant to DPP-4 degradation. Stimulates pituitary GH release via GHRH receptor, induces physiological GH profile, raising IGF-1 safely.

Clinical Applications:

Rheumatoid Arthritis (RA) and Autoimmune Inflammation – Reduces IL-6, TNF-α, NF-κB, and CRP.
Tissue & Cartilage Repair – Promotes chondrocyte proliferation and ECM restoration.
Muscle Maintenance & Regeneration – Counters sarcopenia and chronic inflammation-induced muscle wasting.
Systemic Inflammation Control – Reduces systemic inflammatory burden through multiple pathways.
Body Composition Improvement – Reduces visceral fat and enhances lean muscle preservation.

Dosage & Administration:

30–90 IU per injection, administered once daily or every other day (EOD) via subcutaneous (SC) or intramuscular (IM) route.

Cycle Length:

Standard cycle is 4 weeks, then reassess symptoms before continuing. Cycles can be repeated as needed for chronic autoimmune or degenerative joint conditions.

Monitoring Parameters:

Inflammatory labs: CRP, ESR, IL-6, TNF-α. Hormonal axis: IGF-1, fasting insulin, testosterone. Musculoskeletal recovery markers: grip strength, muscle mass (DEXA).

Patients should be reassessed for inflammatory markers, joint pain, mobility, and muscle recovery before extending cycles.

Synergistic Mechanisms:

GH Axis Stimulation – Triple-pulse GH surge → ↑ IGF-1, anabolic repair
Tissue Repair – Joint, muscle, and synovial repair via satellite cell activation
Immune Modulation – Reduces RA autoimmune misfiring via Treg restoration
Anti-Inflammatory Signaling – Suppress NF-κB, IL-6, TNFα, CRP
Muscle Regeneration – Boosts hypertrophy, counters wasting, enhances recovery

The post Axis: GHRP-2 + Ipamorelin + PEG-MGF + Thymalin + Tesamorelin) appeared first on Cellgenic.

Auron: NAD+ 1000mg

Oliverbravo — Sat, 27 Sep 2025 18:13:13 +0000

What is NAD+ 1000mg?

NAD+ (Nicotinamide Adenine Dinucleotide) is a critical coenzyme involved in cellular energy production, DNA repair, and anti-aging processes. This therapeutic protocol supports mitochondrial optimization, neuroprotection, and longevity enhancement.

NAD+ 1000MG

EXTENDED PROTOCOL

Mechanistic Pathways:

NAD+ → Sirtuin Activation: Improves stress resistance, metabolic regulation, and DNA stability. NAD+ → PARP Enzymes: Repairs oxidative DNA damage, protecting genomic integrity. NAD+ → AMPK Synergy: Enhances autophagy, mitochondrial biogenesis, and insulin sensitivity.

Clinical Notes:

Daily dosing provides consistent mitochondrial and systemic NAD+ repletion. IV administration may provide more rapid systemic saturation; IM/pen delivery allows patient-friendly daily home use.

Therapeutic Applications:

Mitochondrial Optimization & Energy Production – Replenishes depleted NAD+ pools and increases ATP production.
Longevity & Anti-Aging Support – Activates sirtuins for DNA repair and cellular resilience.
Neuroprotection & Cognitive Support – Protects against neurodegenerative stress and enhances neuronal repair.
DNA Repair & Cellular Detoxification – Fuels PARP enzymes and supports liver detox pathways.
Adjunct in Regenerative Therapies – Enhances stem cell and peptide therapy outcomes.

Dosage & Administration:

30 IU daily via Intramuscular (IM) or Intravenous (IV) depending on patient preference and tolerance.

Cycle Length:

4–6 weeks for fatigue, detox, and recovery support. 8–12 weeks for neurodegeneration, cognitive decline, anti-aging, and long-term mitochondrial restoration.

Monitoring Parameters:

Fatigue cases: Track energy levels, mitochondrial biomarkers, lactate clearance. Neuro cases: Cognitive testing, neuroinflammatory markers. Detox cases: Liver enzymes, oxidative stress markers, CRP.

Cycle Reassessment: After 4 weeks, evaluate energy, cognitive performance, and biomarkers (NAD+/NADH ratio, oxidative stress markers, inflammatory cytokines).

Treatment Protocols:

Short-term protocol: 4–6 weeks for immediate support
Long-term protocol: 8–12 weeks for comprehensive restoration
Daily dose: 30 IU consistently
Administration: IM or IV based on patient needs

The post Auron: NAD+ 1000mg appeared first on Cellgenic.

PT-141 10mg

Oliverbravo — Sat, 27 Sep 2025 18:07:48 +0000

What is PT 141?

A peptide that enhances sexual desire in men and women. Also being studied for its effects on mood and anxiety.

PT-141 (BREMELANOTIDE) | 10MG

APPLICATION PROTOCOL

Clinical evidence:

Studies show increased sexual desire and function in both men and women.

Peptide combinations:

PT-141 can be combined with Melanotan II for synergistic effects on sexual health, or with Ipamorelin to enhance sexual function while increasing energy and endurance.

Benefits:

Boosts libido and sexual response.
Improves erectile function and circulation.
Increases sensitivity and orgasm quality.
No mental side effects or euphoria.
May improve confidence, mood, and reduce stress.

Usage and dosage:

The dose of the PT141 peptide may vary according to the individual needs of the patient. Normally, the initial dose is 400 mcg to 700 mcg of PT 141. Expected effect from 1 to 6 hours.

Administration schedule:

First schedule: 8 subcutaneous units up to 7 hours before sexual contact preferably at night and another 5 units in the morning. Expected effect: in the following 30 hours. Second schedule: 10-12 units several hours before sexual contact.

Additional usage instructions:

Inject subcutaneously into the abdominal area or the front part of the thigh. After injecting the product, wait 10 seconds before removing the needle. It is recommended to rotate the injection site.

A pen contains 200 units per 50 micrograms.

Examples of calculated units from the PT-141 pen (10mg) corresponding to micrograms:

1 unit = 50mcg
5 units = 250mcg
10 units = 500mcg
12 units = 600mcg
15 units = 750mcg

Possible side effects:

Mild headaches, nausea, skin redness, or increased blood pressure—usually temporary.

The post PT-141 10mg appeared first on Cellgenic.

Longevity pen

Oliverbravo — Sat, 27 Sep 2025 18:04:03 +0000

What Is the Longevity Pen?

A pre-mixed pen with Glutathione, Resveratrol, and NAD+ to support cellular health, energy, and anti-aging.

LONGEVITY PEN | GLUTATHIONE, NAD+, & RESVERATROL – 1200MG/3ML

APPLICATION PROTOCOL

What makes it special?

Targets three key areas: Detox and oxidative stress protection (Glutathione), Gene activation for longevity (Resveratrol), and Mitochondrial energy and repair (NAD+).

Ingredients:

Glutathione (600 mg): Body’s main antioxidant. Resveratrol (500 mg): Activates the SIRT1 longevity gene. NAD+ (100 mg): Key for energy and DNA repair.

Synergistic effect:

These compounds boost each other’s effects, promoting long-term cell health and resilience.

Benefits:

Improves mitochondrial energy.
Slows cellular aging.
Reduces oxidative stress and inflammation.
Supports DNA repair and immune health.

Usage and dosage:

Suggested protocol for research: 20 units per day for 15 consecutive days, followed by a 15-day pause.

Additional usage instructions:

Inject subcutaneously into the abdominal area or the front part of the thigh. After injecting the product, wait 10 seconds before removing the needle. It is recommended to rotate the injection site.

Total: 300 units per pen

Dosage calculations for Longevity Pen:

1 unit = 400mcg
20 units = 8mg (daily suggested dose)
300 units = 120mg total per pen

The post Longevity pen appeared first on Cellgenic.

DSIP 5mg

Oliverbravo — Sat, 27 Sep 2025 18:01:33 +0000

What is DSIP (Delta-Sleep-Inducing Peptide)?

DSIP is a neuropeptide discovered in the 1970s, known for promoting deep, restorative sleep—specifically increasing delta brain waves during sleep. It acts on the central nervous system and is being studied for its effects on sleep disorders, stress, pain, and more.

DELTA SLEEP INDUCING PEPTIDE (DSIP) | 5MG

APPLICATION PROTOCOL

Mechanism of Action:

Induces delta-wave (slow-wave) sleep, enhancing deep, restorative non‑REM sleep without typical sedation. Believed to interact with GABA, NMDA, α₁‑adrenergic and possibly NMDA receptors.

HPA Axis Modulation:

Modulates the HPA axis by suppressing ACTH/cortisol, stimulating LH and growth hormone, and inhibiting somatostatin.

Clinical Trials:

DSIP is still in early research phases. Some studies report improved sleep quality, reduced stress, better hormonal balance, and antioxidant effects. Preliminary data also suggest possible support for pain relief, cognitive function, and reproductive health.

Benefits of DSIP:

Promotes deep and restful sleep.
May reduce stress and anxiety.
Shows potential antioxidant effects.
May help manage chronic pain.
Could regulate hormone levels and endocrine functions.
May support immune system function.
Investigated for addiction treatment support.
May help normalize blood pressure.
Supports circadian rhythm balance.
Potential benefits for focus and memory.

Usage and dosage:

DSIP is typically administered once daily at 250 mcg to 450 mcg, equal to 10 to 18 units using a peptide dosing pen. A full cycle usually lasts 1 to 2 months, followed by a rest period of equal duration.

Additional usage instructions:

Inject subcutaneously into the abdomen or thigh. Wait 10 seconds before removing the needle. Rotate injection sites to avoid irritation.

Pen Information (5 mg pen = 200 units of 25 mcg): One pen lasts approximately 15 to 20 days, depending on the daily dose.
Storage conditions: 2-8°C

Dosage calculations for DSIP 5mg pen (200 units of 25 mcg each):

1 unit = 25 mcg
10 units = 250 mcg
16 units = 400 mcg
18 units = 450 mcg

The post DSIP 5mg appeared first on Cellgenic.